Healthcare Industry News: MAYFIELD
News Release - November 1, 2010
Integra LifeSciences Awarded Three Contracts With The Broadlane Group to Provide Dural Substitute, Neuro Trauma and Hydrocephalus ProductsPLAINSBORO, N.J., Nov. 1, 2010 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART ) announced today that it has signed a multi-year contract with The Broadlane Group to provide dural repair, neuro trauma (neuro critical care), and hydrocephalus products and accessories to its client hospitals.
"We are very excited that The Broadlane Group has selected Integra as a contracted partner to supply market leading neurosurgical products to its clients," said Chris Thatcher President, Integra Neurosurgery. "This is our first contract with The Broadlane Group for these product categories, and it reflects our commitment to provide The Broadlane Group clients with Integra's highest quality products and services."
Integra is one of the world's largest suppliers of neurosurgical products. "Our DuraGen(R) family of products for dural repair offers neurosurgeons a complete line of dural substitutes, backed by an extensive safety record and proven in over 750,000 procedures," said Tim McCarthy, Vice President of Sales. "Additionally, Integra's products for neuro trauma (neuro critical care), such as Licox(R) and Camino(R) monitoring systems, help limit uncertainty in the important area of monitoring patients in a hospital's Neuro Intensive Care Unit. Broadlane clients will also have access to Integra products for the management of hydrocephalus. Integra's OSV II(R) and Integra NPH(TM) systems offer a unique flow-regulating valve that constantly adjusts to meet a patient's changing physiological requirements without the need for external programming. These products are backed by Integra's unparalleled sales support."
Integra is a leading provider of products used for dural repair, tissue ablation, management of hydrocephalus, neuro monitoring and drainage. Brands associated with Integra are DuraGen(R), CUSA(R), Camino(R), Licox(R), OSV II(R), Integra NPH(TM), MAYFIELD(R) and Ruggles(TM)-Redmond(TM) instruments.
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com
About The Broadlane Group
The Broadlane Group is dedicated to making quality healthcare affordable. Delivering supply chain management, strategic sourcing of supplies and services, capital equipment lifecycle management, clinical and lean process consulting, and clinical workforce optimization, the company serves more than 1,100 acute care hospitals and 50,000 non-acute care facilities across the United States. The Broadlane Group's comprehensive and customizable solutions empower healthcare providers of all sizes to achieve dramatic operating margin improvements. For more information, visit www.broadlane.com.
MAYFIELD is a registered trademark of SM USA, Inc. and is used by Integra under license.
Source: Integra LifeSciences
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.